INVO Fertility, Inc. Income (Loss) from Continuing Operations, Per Diluted Share
INVO Fertility, Inc. (IVF) reported Income (Loss) from Continuing Operations, Per Diluted Share of $0.35 per share for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:IncomeLossFromContinuingOperationsPerDilutedShare · last filed 2026-08-14
- INVO Fertility, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2026-06-30 was $0.35.
- INVO Fertility, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2026-03-31 was -$3.38.
- INVO Fertility, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-09-30 was -$39.40.
- INVO Fertility, Inc. income (loss) from continuing operations, per diluted share for the quarter ending 2025-06-30 was -$155.31.
- INVO Fertility, Inc. income (loss) from continuing operations, per diluted share for fiscal 2025 was -$45.57.
- INVO Fertility, Inc. income (loss) from continuing operations, per diluted share for fiscal 2024 was -$3078.74.
| Period end | Income (Loss) from Continuing Operations, Per Diluted Share 3 month | Income (Loss) from Continuing Operations, Per Diluted Share 3 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 6 month | Income (Loss) from Continuing Operations, Per Diluted Share 6 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 9 month | Income (Loss) from Continuing Operations, Per Diluted Share 9 month as first filed | Income (Loss) from Continuing Operations, Per Diluted Share 12 month |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.35 10-Q · filed 2026-08-14 | -$2.48 10-Q · filed 2026-08-14 | |||||
| 2026-03-31 | -$3.38 10-Q · filed 2026-06-22 | ||||||
| 2025-12-31 | -$45.57 10-K · filed 2026-06-02 | ||||||
| 2025-09-30 | -$39.40 10-K · filed 2026-06-02 | -$0.77 10-Q · filed 2025-11-17 | -$181.05 10-K · filed 2026-06-02 | -$5.17 10-Q · filed 2025-11-17 | |||
| 2025-06-30 | -$155.31 10-Q · filed 2026-08-14 | -$7.95 10-Q · filed 2025-08-14 | -$405.93 10-Q · filed 2026-08-14 | -$15.72 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | -$297.87 10-Q · filed 2026-06-22 | ||||||
| 2024-12-31 | -$3078.74 10-K · filed 2026-06-02 | ||||||
| 2024-09-30 | -$15.11 10-Q · filed 2025-11-17 | -$58.88 10-Q · filed 2025-11-17 | |||||
| 2024-06-30 | -$22.39 10-Q · filed 2025-08-14 | -$45.01 10-Q · filed 2025-08-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Profusa, Inc. (PFSA) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |